Cell therapy for ischemic stroke: Are differences in preclinical and clinical study design responsible for the translational loss of efficacy?

Saved in:
Bibliographic Details
Published inAnnals of neurology Vol. 86; no. 1; pp. 5 - 16
Main Authors Cui, Li‐li, Golubczyk, Dominika, Tolppanen, Anna‐Maija, Boltze, Johannes, Jolkkonen, Jukka
Format Journal Article
LanguageEnglish
Published Hoboken, USA John Wiley & Sons, Inc 01.07.2019
Wiley Subscription Services, Inc
Subjects
Animals
Brain Ischemia - diagnosis
Brain Ischemia - therapy
Cell- and Tissue-Based Therapy - methods
Cell- and Tissue-Based Therapy - trends
Clinical Trials as Topic - methods
Disease Models, Animal
Humans
Ischemia
Stroke
Stroke - diagnosis
Stroke - therapy
Translational Medical Research - methods
Translational Medical Research - trends
Treatment Outcome
Online AccessGet full text

Cover

More Information
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ISSN:0364-5134
1531-8249
1531-8249
DOI:10.1002/ana.25493